Literature DB >> 332309

Type A and type B botulism in the North: first reported cases due to toxin other than type E in Alaskan Inuit.

D H Barrett, M S Eisenberg, T R Bender, J M Burks, C L Hatheway, V R Dowell.   

Abstract

Botulism outbreaks shown to be due to type A and type B toxin occurred in Alaska, a region previously known for only type E botulism. The outbreak due to type A toxin involved three people, two of whom died. The outbreak due to type B toxin involved nine people, none of whom died. Both outbreaks were in Inuit villages, and native foods were incriminated. The occurrence of these outbreaks strongly suggests that Clostridium botulinum, types A and B are indigenous to Alaska. The outbreaks underscore the need for initial treatment of patients with antitoxin that is trivalent (ABE), even in Arctic regions.

Entities:  

Mesh:

Year:  1977        PMID: 332309      PMCID: PMC1879961     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  11 in total

1.  Current trends in botulism in the United States.

Authors:  M H Merson; J M Hughes; V R Dowell; A Taylor; W H Barker; E J Gangarosa
Journal:  JAMA       Date:  1974-09-02       Impact factor: 56.272

2.  [Type E botulism. 2 epidemics at Fort Chimo].

Authors:  D Audet; Y Landry; L Gauvreau; S Petrow; S S Kasatiya; M A Johnston
Journal:  Union Med Can       Date:  1973-08

3.  Possible origin of Clostridium botulinum contamination of Eskimo foods in northwestern Alaska.

Authors:  L G Miller; P S Clark; G A Kunkle
Journal:  Appl Microbiol       Date:  1972-02

4.  Incidence of Clostridium botulinum type E in Alaskan salmon.

Authors:  G A Houghtby; C A Kaysner
Journal:  Appl Microbiol       Date:  1969-11

5.  Botulism among Cape Dorset Eskimos and suspected botulism at Frobicher Bay and Wakeham Bay.

Authors:  P F Stuart; E J Wiebe; R McElroy; D G Cameron; E C Todd; I E Erdman; B Albalas; H Pivnick
Journal:  Can J Public Health       Date:  1970 Nov-Dec

6.  Trivalent botulinus antitoxin.

Authors:  M G Koenig
Journal:  Ann Intern Med       Date:  1969-03       Impact factor: 25.391

7.  Observations on the distribution and ecology of Clostridium botulinum type E in Alaska.

Authors:  L G Miller
Journal:  Can J Microbiol       Date:  1975-06       Impact factor: 2.419

8.  Syndrome of botulism in infancy: clinical and electrophysiologic study.

Authors:  J Pickett; B Berg; E Chaplin; M A Brunstetter-Shafer
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

9.  Human botulism in Canada (1919-1973).

Authors:  C E Dolman
Journal:  Can Med Assoc J       Date:  1974-01-19       Impact factor: 8.262

10.  Infant botulism. Identification of Clostridium botulinum and its toxins in faeces.

Authors:  T F Midura; S S Arnon
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

View more
  4 in total

1.  Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923-2016.

Authors:  John C O'Horo; Eugene P Harper; Abdelghani El Rafei; Rashid Ali; Daniel C DeSimone; Amra Sakusic; Omar M Abu Saleh; Jasmine R Marcelin; Eugene M Tan; Agam K Rao; Jeremy Sobel; Pritish K Tosh
Journal:  Clin Infect Dis       Date:  2017-12-27       Impact factor: 9.079

2.  Distribution of Clostridium botulinum type E strains in Nunavik, Northern Quebec, Canada.

Authors:  Daniel Leclair; Jeffrey M Farber; Bill Doidge; Burke Blanchfield; Sandy Suppa; Franco Pagotto; John W Austin
Journal:  Appl Environ Microbiol       Date:  2012-11-16       Impact factor: 4.792

3.  Comparison of DNA fingerprinting methods for use in investigation of type E botulism outbreaks in the Canadian Arctic.

Authors:  Daniel Leclair; Franco Pagotto; Jeffrey M Farber; Brigitte Cadieux; John W Austin
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  Tracking sources of Clostridium botulinum type E contamination in seal meat.

Authors:  Daniel Leclair; Jeffrey M Farber; Franco Pagotto; Sandy Suppa; Bill Doidge; John W Austin
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.